These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35970014)

  • 1. PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment.
    Thouvenin J; Van Marcke C; Decoster L; Raicevic G; Punie K; Vandenbulcke M; Salgado R; Van Valckenborgh E; Maes B; Joris S; Steichel DV; Vranken K; Jacobs S; Dedeurwaerdere F; Martens G; Devos H; Duhoux FP; Rasschaert M; Pauwels P; Geboes K; Collignon J; Tejpar S; Canon JL; Peeters M; Rutten A; Van de Mooter T; Vermeij J; Schrijvers D; Demey W; Lybaert W; Van Huysse J; Mebis J; Awada A; Claes KBM; Hebrant A; Van der Meulen J; Delafontaine B; Bempt IV; Maetens J; de Hemptinne M; Rottey S; Aftimos P; De Grève J
    ESMO Open; 2022 Aug; 7(4):100524. PubMed ID: 35970014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09.
    Kim SY; Kim JH; Kim TY; Park SR; Yoon S; Lee S; Lee SH; Kim TM; Han SW; Kim HR; Yun H; Lee S; Kim J; Choi YL; Choi KS; Chae H; Ryu H; Lee GW; Zang DY; Ahn JB
    BMC Cancer; 2024 May; 24(1):574. PubMed ID: 38724991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
    Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
    Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision cancer medicine: What has translated into clinical use in Belgium?
    Delnord M; Van Valckenborgh E; Hebrant A; Antoniou A; Van Hoof W; Waeytens A; Van den Bulcke M
    Semin Cancer Biol; 2022 Sep; 84():255-262. PubMed ID: 34129914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial.
    Kringelbach T; Højgaard M; Rohrberg K; Spanggaard I; Laursen BE; Ladekarl M; Haslund CA; Harsløf L; Belcaid L; Gehl J; Søndergaard L; Eefsen RL; Hansen KH; Kodahl AR; Jensen LH; Holt MI; Oellegaard TH; Yde CW; Ahlborn LB; Lassen U
    BMC Cancer; 2023 Feb; 23(1):182. PubMed ID: 36814246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors for Identification of Targeted Therapy Opportunities.
    Matsubara J; Mukai K; Kondo T; Yoshioka M; Kage H; Oda K; Kudo R; Ikeda S; Ebi H; Muro K; Hayashi R; Tokudome N; Yamamoto N; Muto M
    JAMA Netw Open; 2023 Jul; 6(7):e2323336. PubMed ID: 37459099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation of a formalized precision medicine program in gynecologic oncology.
    Gunderson CC; Rowland MR; Wright DL; Andrade KL; Mannel RS; McMeekin DS; Moore KN
    Gynecol Oncol; 2016 Apr; 141(1):24-8. PubMed ID: 27016225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision oncology based on omics data: The NCT Heidelberg experience.
    Horak P; Klink B; Heining C; Gröschel S; Hutter B; Fröhlich M; Uhrig S; Hübschmann D; Schlesner M; Eils R; Richter D; Pfütze K; Geörg C; Meißburger B; Wolf S; Schulz A; Penzel R; Herpel E; Kirchner M; Lier A; Endris V; Singer S; Schirmacher P; Weichert W; Stenzinger A; Schlenk RF; Schröck E; Brors B; von Kalle C; Glimm H; Fröhling S
    Int J Cancer; 2017 Sep; 141(5):877-886. PubMed ID: 28597939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing the European Society for Medical Oncology Scale for Clinical Actionability of Molecular Targets in a Comprehensive Profiling Program: Impact on Precision Medicine Oncology.
    Martin-Romano P; Mezquita L; Hollebecque A; Lacroix L; Rouleau E; Gazzah A; Bahleda R; Planchard D; Varga A; Baldini C; Postel-Vinay S; Friboulet L; Loriot Y; Verlingue L; Geraud A; Camus MN; Nicotra C; Soria JC; André F; Besse B; Massard C; Italiano A
    JCO Precis Oncol; 2022 Oct; 6():e2100484. PubMed ID: 36315916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCRUM-Japan GI-SCREEN and MONSTAR-SCREEN: Path to the realization of biomarker-guided precision oncology in advanced solid tumors.
    Nakamura Y; Fujisawa T; Taniguchi H; Bando H; Okamoto W; Tsuchihara K; Yoshino T; Ohtsu A
    Cancer Sci; 2021 Nov; 112(11):4425-4432. PubMed ID: 34510657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative.
    Pishvaian MJ; Bender RJ; Halverson D; Rahib L; Hendifar AE; Mikhail S; Chung V; Picozzi VJ; Sohal D; Blais EM; Mason K; Lyons EE; Matrisian LM; Brody JR; Madhavan S; Petricoin EF
    Clin Cancer Res; 2018 Oct; 24(20):5018-5027. PubMed ID: 29954777
    [No Abstract]   [Full Text] [Related]  

  • 12. From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.
    Perera-Bel J; Hutter B; Heining C; Bleckmann A; Fröhlich M; Fröhling S; Glimm H; Brors B; Beißbarth T
    Genome Med; 2018 Mar; 10(1):18. PubMed ID: 29544535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing precision cancer medicine in the genomic era.
    Chen HZ; Bonneville R; Roychowdhury S
    Semin Cancer Biol; 2019 Apr; 55():16-27. PubMed ID: 29857039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.
    Coyne GO; Takebe N; Chen AP
    Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus Statements on Precision Oncology in the China Greater Bay Area.
    Lam TC; Cho WC; Au JS; Ma ES; Lam ST; Loong HH; Wong JWH; Wong SNM; Lee VH; Leung RC; Lau JK; Kam MT; Mok FS; Lim FM; Nyaw JS; Tin WW; Cheung KM; Chan OS; Kwong PW; Cheung FY; Poon DMC; Chik JY; Lam MH; Chan LW; Wong SC; Cao YB; Hui CV; Chen JZ; Chang JH; Kong SF; El Helali A;
    JCO Precis Oncol; 2023 Jun; 7():e2200649. PubMed ID: 37315266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center Experience.
    Seet AOL; Tan AC; Tan TJ; Ng MCH; Tai DWM; Lam JYC; Tan GS; Gogna A; Too CW; Tan BS; Takano A; Lim A; Lim TH; Lim ST; Dent RA; Ang MK; Yap YS; Tan IBH; Choo SP; Toh CK; Lim EH; Farid M; Skanderup AJ; Iyer NG; Lim WT; Tan EH; Lim TKH; Tan DSW
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34250396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision Oncology: Who, How, What, When, and When Not?
    Schwartzberg L; Kim ES; Liu D; Schrag D
    Am Soc Clin Oncol Educ Book; 2017; 37():160-169. PubMed ID: 28561651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer.
    Keller RB; Mazor T; Sholl L; Aguirre AJ; Singh H; Sethi N; Bass A; Nagaraja AK; Brais LK; Hill E; Hennessey C; Cusick M; Del Vecchio Fitz C; Zwiesler Z; Siegel E; Ovalle A; Trukhanov P; Hansel J; Shapiro GI; Abrams TA; Biller LH; Chan JA; Cleary JM; Corsello SM; Enzinger AC; Enzinger PC; Mayer RJ; McCleary NJ; Meyerhardt JA; Ng K; Patel AK; Perez KJ; Rahma OE; Rubinson DA; Wisch JS; Yurgelun MB; Hassett MJ; MacConaill L; Schrag D; Cerami E; Wolpin BM; Nowak JA; Giannakis M
    JCO Precis Oncol; 2023 Jan; 7():e2200342. PubMed ID: 36634297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Approach to Solving the Complex Clinicogenomic Data Landscape in Precision Oncology: Learnings From the Design of WAYFIND-R, a Global Precision Oncology Registry.
    Le Tourneau C; Perret C; Hackshaw A; Blay JY; Nabholz C; Geissler J; Do T; von Meyenn M; Dienstmann R
    JCO Precis Oncol; 2022 Jul; 6():e2200019. PubMed ID: 35939770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations of developing an NGS assay for clinical applications in precision oncology: The NCI-MATCH NGS assay experience.
    Lih CJ; Takebe N
    Curr Probl Cancer; 2017; 41(3):201-211. PubMed ID: 28625332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.